Illumina, Inc. Launches MicroRNA Assay for Gene Expression Profiling

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today launched a MicroRNA Assay for Gene Expression profiling. Priced at $95 per sample, this assay is the only solution available to allow rapid and reproducible miRNA expression profiling at a price less than half that of other commercially available methods. By developing a high-density expression array with content from the miRBase Sequence Database this new tool will help researchers better understand the role microRNAs (miRNA) play in regulating messenger RNA (mRNA).

MORE ON THIS TOPIC